Giacomo Masi | Cellular Senescence Aging | Cellular Senescence Award

Dr. Giacomo Masi | Cellular Senescence Aging | Cellular Senescence Award

Dr. Giacomo Masi | VitroScreen | Italy

Giacomo Masi is a Biomedical Engineer with a specialized background in cellular models and tissue engineering. Graduated with a Master’s Degree in Bioengineering from the University of Genoa, he has conducted research in the development and validation of 3D in vitro models to study complex biological processes. His academic and professional trajectory has led him to work on high-impact research themes such as neurodegeneration, tissue perfusion, and cellular senescence. Masi’s dynamic and proactive approach is reflected in his cross-disciplinary skillset, ranging from 3D bioprinting to immunohistochemistry and flow cytometry. He is currently engaged at VitroScreen, Milan, contributing to GLP-compliant preclinical testing using advanced 3D platforms. His ultimate goal is to support precision medicine through biomimetic model development, focusing on aging-related cellular dysfunctions. With two peer-reviewed publications and ongoing collaborations, Masi is steadily building a career dedicated to biomedical innovation and translational research.

Publication Profile: 

Google Scholar

Education:

Giacomo Masi holds a Master’s Degree in Bioengineering from the University of Genoa, where he graduated with a score  and a Bachelor’s Degree in Biomedical Engineering from the Università Politecnica delle Marche . During his academic training, he specialized in tissue engineering, cellular biology, and biomaterials, complementing theoretical knowledge with hands-on experience in cell culture, imaging, and lab instrumentation. His thesis and research projects often intersected with real-world biomedical challenges, such as replicating complex tissue environments for drug testing or studying neurodevelopment in vitro. He also developed a working knowledge of MATLAB, C, and Adobe tools for scientific visualization and data analysis. Masi’s education laid a strong foundation in both engineering principles and life sciences, equipping him with the interdisciplinary mindset necessary for modern biomedical research, particularly in aging, cellular dysfunction, and regenerative technologies.

Experience:

Masi’s professional journey includes a research fellowship at the University of Genoa, where he contributed to the “Smart BioInks” project focusing on 3D bioprinting and hydrogel development. He designed and validated 3D scaffolds and conducted advanced 2D/3D cell culture with iPSCs and neuronal lines. He has been working at VitroScreen (Milan) as a GLP laboratory technician, specializing in 3D in vitro models for studying tissue barriers and cellular responses. His tasks include immunohistological and metabolic characterization, test standardization (SOPs), and cytotoxicity assays like MTT and TEER. His work contributes to regulatory studies aligned with OECD and ISO guidelines, and he also participates in scientific writing and publishing. These experiences reflect Masi’s competence in translational research, where rigorous lab techniques meet biomedical innovation, making him a valuable contributor in the fields of senescence, drug screening, and disease modeling.

Awards & Honors:

While Giacomo Masi has yet to receive formal academic awards, his most significant honors lie in his peer-reviewed publications and institutional recognition through research funding. His selection as a research fellow at the University of Genoa and subsequent employment at VitroScreen, a leader in advanced in vitro models, indicate trust and acknowledgment from the academic and industrial sectors. Moreover, co-authorship in international journals like APL Bioengineering and Organoids demonstrates the scientific value of his contributions. These publications, particularly the one on senescence-related hair loss mechanisms, showcase his direct impact in aging and cellular dysfunction research. His continued involvement in GLP-certified studies and international dissemination of findings (via conference posters and manuscript drafting) is a testament to his growing influence. Masi’s focus on research quality, reproducibility, and clinical relevance positions him for future awards as his career progresses.

Research Focus:

Giacomo Masi’s research is centered around the development of advanced 3D in vitro models to better replicate human tissue physiology and pathophysiology. A key focus is cellular senescence and aging, as seen in his publication on mimicking senescence signals to understand hair follicle regression and hair loss. He leverages bioprinting, hydrogels, and scaffold engineering to create environments where cells exhibit in vivo-like behavior. His models aim to bridge the gap between preclinical testing and clinical outcomes, offering personalized medicine platforms for drug screening and toxicity testing. At VitroScreen, he’s also engaged in barrier models using TEER and metabolic readouts, useful in aging and degenerative studies. His long-term goal is to enable early disease modeling, particularly in neurodegeneration and dermatology, using non-animal, human-relevant systems. Masi’s work is particularly aligned with modern needs for precision medicine, reduction of animal use, and aging research.

Publications Top Notes:

  1.  “Impact of perfusion on neuronal development in human derived neuronal networks” – APL Bioengineering,

  2. “Mimicking Senescence Factors to Characterize the Mechanisms Responsible for Hair Regression and Hair Loss: An In Vitro Study” – Organoids,

Conclusion:

In conclusion, Giacomo Masi is a strong and promising candidate for the Research for Cellular Senescence Award. His combined academic training, technical expertise, and direct contributions to in vitro models mimicking senescence mechanisms position him well within the scope and objectives of the award. With a proactive attitude, a clear research focus on tissue engineering and personalized medicine, and relevant scientific output, he represents the new generation of biomedical researchers pushing the boundaries in aging and disease modeling. Strengthening his international collaborations and deepening the theoretical narrative around senescence in his research would elevate his profile even further. Nonetheless, based on current credentials and output, he is well-suited and deserving of recognition through this award.

 

Yizhong Peng | Cellular Senescence Aging | Best Researcher Award

Dr. Yizhong Peng | Cellular Senescence Aging | Best Researcher Award

Dr. Yizhong Peng , Wuhan Union Hospital , China

Dr. Peng Yizhong is an attending physician at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, specializing in orthopedic spine and sports injuries. As a recipient of prestigious awards like the Postdoctoral Pioneer Talent Tracking Support Program and a Wuhan Talent, Dr. Peng has demonstrated exceptional contributions to both clinical practice and research. His work, supported by several grants from the National Natural Science Foundation of China, China Postdoctoral Science Foundation, and Hubei Province, highlights his expertise and commitment to advancing medical knowledge in orthopedics. With 30 published papers in leading journals, 15 granted patents, and significant contributions to the medical field, Dr. Peng is a recognized authority in his field. Additionally, he serves as a reviewer and editorial board member for high-impact journals.

Publication Profile:

Scopus

Strengths for the Award:

  1. Extensive Research Contribution: Dr. Peng has made significant contributions to orthopedic spine and sports injury research, with over 30 published papers in highly regarded journals such as Advanced Science, ACS Nano, Acta Pharmaceutica Sinica B, and Bioactive Materials. His publications reflect both a deep understanding and innovative approaches to addressing musculoskeletal disorders.

  2. Innovation and Patents: He has been granted 15 patents, including 2 international patents and 2 invention patents, showcasing his ability to translate research into practical, groundbreaking technologies in the field of orthopedics and regenerative medicine.

  3. Leadership in Research Projects: As the principal investigator for several major projects funded by prestigious bodies like the National Natural Science Foundation of China and China Postdoctoral Science Foundation, Dr. Peng has led key studies that contribute to the advancement of both clinical practices and technological innovations in orthopedic treatments.

  4. Academic Engagement: His role as an editorial board member for Biomaterials Translational and Exploration and a reviewer for high-impact journals highlights his prominence in the academic community. His collaborative nature further enhances his visibility and reputation among peers.

  5. Commitment to Patient Care: His dual focus on clinical applications and advanced research positions Dr. Peng as a well-rounded professional who not only generates knowledge but also translates it into impactful patient care.

Areas for Improvement:

  1. Broader Collaboration: While Dr. Peng has shown exceptional leadership in his specific research areas, broadening his collaborations with interdisciplinary teams or researchers from different regions could potentially expand his impact further, especially in global research environments.

  2. Public Engagement: Engaging more directly with the public, through outreach or educational initiatives, could help disseminate his findings and innovations to a broader audience, potentially benefiting more individuals affected by musculoskeletal conditions.

  3. International Recognition: Though Dr. Peng has made remarkable strides within China, increasing his presence and collaboration in international research conferences and publishing in global journals could help elevate his international recognition.

Education:

Dr. Peng Yizhong completed his education at prestigious institutions, where he earned his Ph.D. and postdoctoral degrees. His academic journey provided a strong foundation in both clinical medicine and research. He completed his postdoctoral research under the Postdoctoral Pioneer Talent Tracking Support Program, focusing on spine and sports injuries. This training equipped him with advanced research methodologies and an in-depth understanding of orthopedic diseases. Dr. Peng’s academic pursuits were further supported by his experience in various interdisciplinary fields, allowing him to approach complex medical problems with innovative solutions. His continuous learning, dedication, and commitment to advancing the field of orthopedics make him a prominent figure in both the academic and clinical research domains.

Experience:

Dr. Peng Yizhong has an extensive career spanning clinical and research roles in orthopedic medicine. As an attending physician at Union Hospital, Tongji Medical College, he specializes in treating spine and sports injuries, offering comprehensive care to patients. In parallel, his research focuses on novel treatment strategies and the development of advanced medical technologies. He has led numerous research projects funded by the National Natural Science Foundation of China, China Postdoctoral Science Foundation, and Hubei Province. His contributions to orthopedic medicine are further reflected in his active participation in international and national conferences, and his role as a young editorial board member of Biomaterials Translational and Exploration. With over 30 research publications and 15 patents, Dr. Peng has made groundbreaking advancements in his field, focusing on nanotechnology, regenerative medicine, and innovative treatment techniques. His interdisciplinary approach combines clinical practice with cutting-edge scientific research.

Research Focus:

Dr. Peng Yizhong’s research is centered on orthopedic spine injuries, sports-related injuries, and the application of advanced nanotechnology in medical treatments. His work explores innovative therapies, particularly in the context of orthopedic regeneration and healing. One of his major research areas involves studying the effects of dual-target nanotherapy, which aims to address steroid-induced osteonecrosis and enhance bone regeneration. Dr. Peng’s work also delves into regenerative medicine through the use of extracellular vesicles, stem cells, and novel drug delivery systems. His interdisciplinary approach is reflected in his exploration of bioactive materials, drug delivery mechanisms, and tissue engineering. Additionally, his research efforts in creating minimally invasive surgical techniques and improving arthroscopic methods have contributed to improved patient outcomes in orthopedic procedures. Through his commitment to both clinical and laboratory-based studies, Dr. Peng is advancing the understanding of complex musculoskeletal conditions and developing novel therapeutic approaches.

Publications Top Notes:

  1. Dual-target nanotherapy for vascular endothelium and bone mesenchymal stem cells halt steroid-induced osteonecrosis of the femoral head progression 🦴💉
  2. Arthroscopic 2-Portal Technique Using Percutaneous Spinal Needle Suture Passing With Suture Anchors for the Treatment of Calcific Insertional Achilles Tendinopathy 🦶🔩
  3. Arthroscopic Reduction and Transosseous Fixation of the Elbow Coronoid Process Fracture Using High-Strength Suture 💪💥
  4. Extracellular vesicles deliver thioredoxin to rescue stem cells from senescence and intervertebral disc degeneration via a feed-forward circuit of the NRF2/AP-1 composite pathway 🔬🧬
  5. A Simplified Technique for All-Inside Tibial Socket Retrograde Drill Guiding Using a 2- to 3.5-mm Concentric Cannula Without the All-Inside Tibial Guide Ring 🦵⚙️

Conclusion:

Dr. Peng Yizhong is undoubtedly a strong candidate for the Best Researcher Award due to his exceptional contributions to the field of orthopedic medicine. His innovative research, patent contributions, and leadership in funded projects, along with his clinical expertise, make him a standout researcher in his field. With further global collaboration and outreach, his impact on both the academic and clinical communities will continue to grow, making him a valuable asset to the medical research world.